Oestrogel (Estradiol)

Estradiol, the active ingredient in Oestrogel, is an estrogen hormone presented as a gel for transtransdermal use. It is used to treat estrogen deficiency symptoms in women, particularly during menopause and after oophorectomy.

GNH USA supplies Oestrogel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oestrogel is an estrogen replacement that acts on the hormonal pathways involved in female reproductive health. - Menopausal symptoms: alleviates hot flashes, night sweats and vaginal dryness. - Hypo‑estrogenism after oophorectomy: restores systemic estrogen levels. - Primary ovarian insufficiency: supports development of secondary sexual characteristics and bone health.

Adverse reactions to Oestrogel vary in frequency and severity.

Common Side Effects: - Skin irritation at application site: redness, itching or mild rash. - Headache: transient mild to moderate pain. - Nausea: occasional upset stomach. - Breast tenderness: mild swelling or discomfort. - Mood changes: irritability or mild depressive symptoms.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Hepatotoxicity: abnormal liver function tests. - Endometrial hyperplasia or carcinoma. - Severe allergic reaction: anaphylaxis or angio‑edema.

When using Oestrogel, patients and clinicians should consider several safety measures. - Contraindications: do not use if history of blood clots or estrogen‑dependent tumors. - Monitoring: periodic assessment of blood pressure, lipid profile and liver enzymes. - Breast health: perform regular mammograms and breast examinations. - Cardiovascular risk: evaluate personal and family history of thromboembolic events. - Bone health: assess bone mineral density in long‑term therapy. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Estradiol may interact with several other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Combined oral contraceptives: increased risk of thromboembolic events. - Anticoagulants (e.g., warfarin): potentiated anticoagulant effect, requiring dose adjustment.\nModerate Interactions (Monitor Closely): - Antiepileptic drugs (phenylenediamine …)